{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:32:04Z","timestamp":1786609924615,"version":"build-2736575974"},"reference-count":32,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vasc Med"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Iloprost has been proposed as a pharmacological option for patients with chronic limb-threatening ischemia (CLTI) in whom revascularization is either not feasible or has been unsuccessful. This pilot study aimed to evaluate the safety and effectiveness of intravenous iloprost at low infusion rates via an elastomeric pump at home (EP-iloprost) versus higher infusion rates via a peristaltic pump in the hospital (PP-iloprost) for 1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a cohort study conducted in \u2018no-option\u2019 patients for revascularization with CLTI. The follow-up was 3 years. The primary endpoint was the incidence of drug-related adverse events (AEs); the secondary outcome was the composite of all-cause death and major amputations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We enrolled 56 patients who received EP-iloprost as a pilot study. Their outcomes were compared with a cohort of 48 patients who had received PP-iloprost. AEs were reported in 15 (31.3%) patients who received PP-iloprost and in eight (14.3%) who received EP-iloprost (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.038), with the exposure-adjusted incidence rate being 22.7\/100 patient-years in the PP-iloprost group and 8.3\/100 patient-years in the EP-iloprost group. Although the two cohorts were not well-suited for comparison due to age differences, there were seven (12.5%) deaths and four (7.1%) major amputations in the EP cohort compared with 11 (22.9%) deaths and 13 (27.1%) major amputations in the PP cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These hypothesis-generating data suggest that low-rate infusion of EP-iloprost at home is better tolerated and potentially more effective than high-rate infusion with PP in a hospital setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1358863x261447258","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:54:04Z","timestamp":1782230044000},"page":"526-534","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Home-based intravenous iloprost by portable elastomeric pump in chronic limb-threatening ischemia: A pilot study"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-4676","authenticated-orcid":false,"given":"Michelangelo","family":"Sartori","sequence":"first","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Favaretto","sequence":"additional","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Zanata","sequence":"additional","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Cavara","sequence":"additional","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Libra","sequence":"additional","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Sonetto","sequence":"additional","affiliation":[{"name":"Vascular Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Gallitto","sequence":"additional","affiliation":[{"name":"Vascular Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"},{"name":"Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gargiulo","sequence":"additional","affiliation":[{"name":"Vascular Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"},{"name":"Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-6038","authenticated-orcid":false,"given":"Benilde","family":"Cosmi","sequence":"additional","affiliation":[{"name":"Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"},{"name":"Angiology and Blood Coagulation Unit, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2024.12.009"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2019.05.006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.100982"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602820963911"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2025.05.004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016111797484107"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313234"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319719889273"},{"issue":"1","key":"e_1_3_2_10_2","article-title":"Prostanoids for critical limb ischaemia","volume":"1","author":"Vietto V","year":"2018","unstructured":"Vietto V, Franco JV, Saenz V, et al. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev 2018; 1(1): CD006544.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X231209263"},{"key":"e_1_3_2_12_2","first-page":"64","article-title":"Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV)","volume":"24","author":"Meini S","year":"2005","unstructured":"Meini S, De Franco V, Auteri A, et al. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV). Int Angiol 2005; 24: 64\u201369.","journal-title":"Int Angiol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01616273"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.08.003"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2019.1653565"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.23.05098-8"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000834"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001251"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1193"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243060-00008"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-07-0499"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(93)90163-Q"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-821X(05)80784-4"},{"key":"e_1_3_2_24_2","first-page":"511","article-title":"Severe Limb Ischaemia Study Group","volume":"5","author":"Treatment of limb threatening ischaemia with intravenous iloprost: A randomised double-blind placebo controlled study. U.K","year":"1991","unstructured":"Treatment of limb threatening ischaemia with intravenous iloprost: A randomised double-blind placebo controlled study. U.K. Severe Limb Ischaemia Study Group. Eur J Vasc Surg 1991; 5: 511\u2013516.","journal-title":"Eur J Vasc Surg"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000217555.49001.ca"},{"key":"e_1_3_2_26_2","first-page":"229","article-title":"Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost","volume":"10","author":"Balzer K","year":"1991","unstructured":"Balzer K, Bechara G, Bisler H, et al. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost. Int Angiol 1991; 10: 229\u2013232.","journal-title":"Int Angiol"},{"key":"e_1_3_2_27_2","first-page":"358","article-title":"The Oral Iloprost in severe Leg Ischaemia Study Group","volume":"20","author":"Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia","year":"2000","unstructured":"Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group. Eur J Vasc Endovasc Surg 2000; 20: 358\u2013362.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"e_1_3_2_28_2","first-page":"502","article-title":"Long-term clinical outcomes in critical limb ischemia \u2013 A retrospective study of 181 patients","volume":"20","author":"Melillo E","year":"2016","unstructured":"Melillo E, Micheletti L, Nuti M, et al. Long-term clinical outcomes in critical limb ischemia \u2013 A retrospective study of 181 patients. Eur Rev Med Pharmacol Sci 2016; 20: 502\u2013508.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4043-0"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(04)80067-5"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2023.11.006"},{"key":"e_1_3_2_32_2","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: A subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch E","year":"2021","unstructured":"Kaplovitch E, Eikelboom JW, Dyal L, et al. Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: A subanalysis of the COMPASS randomized clinical trial. JAMA Cardiol 2021; 6: 21\u201329.","journal-title":"JAMA Cardiol"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2000052"}],"container-title":["Vascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X261447258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1358863X261447258","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X261447258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:26:14Z","timestamp":1786609574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1358863X261447258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/1358863X261447258"],"URL":"https:\/\/doi.org\/10.1177\/1358863x261447258","relation":{},"ISSN":["1358-863X","1477-0377"],"issn-type":[{"value":"1358-863X","type":"print"},{"value":"1477-0377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}